Paper8749640
Treatment of cerebral Aspergillosis with itraconazole: do high doses improve the prognosis?
Sánchez C and 5 others. Clin Infect Dis, 1995. Cited by 51 papers, by iCite.
Cite this record
ConductScience Library. Treatment of cerebral Aspergillosis with itraconazole: do high doses improve the prognosis? Papers, record 8749640. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8749640
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Treatment of cerebral Aspergillosis with itraconazole: do high doses improve the prognosis?
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antifungal Agents | Major topic |
| Aspergillosis | Major topic |
| Aspergillus fumigatus | Major topic |
| Brain Abscess | Major topic |
| Itraconazole | Major topic |
| Aged | |
| Dose-Response Relationship, Drug | |
| Female | |
| Follow-Up Studies | |
| Humans | |
| Prognosis | |
| Tomography, X-Ray Computed |
Source PubMed
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Comment in | 8922839 | High-dose itraconazole for the treatment of cerebral aspergillosis. | https://conductscience.org/library/papers/8922839 |
Source PubMed
Cited by8
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 51 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 27052648 | CNS infections in patients with hematological disorders (including allogeneic stem-cell transplantation)-Guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO). | Ann Oncol | 2016 | https://conductscience.org/library/papers/27052648 | PubMed |
| 25932045 | Repurposing Drugs in Oncology (ReDO)-itraconazole as an anti-cancer agent. | Ecancermedicalscience | 2015 | https://conductscience.org/library/papers/25932045 | PubMed |
| 23384533 | Reflections on the approach to treatment of a mycologic disaster. | Antimicrob Agents Chemother | 2013 | https://conductscience.org/library/papers/23384533 | PubMed |
| 21875960 | Necessary and sufficient role for T helper cells to prevent fungal dissemination in allergic lung disease. | Infect Immun | 2011 | https://conductscience.org/library/papers/21875960 | PubMed |
| 20385363 | Itraconazole, a commonly used antifungal that inhibits Hedgehog pathway activity and cancer growth. | Cancer Cell | 2010 | https://conductscience.org/library/papers/20385363 | PubMed |
| 17630818 | CNS aspergillosis: recognition, diagnosis and management. | CNS Drugs | 2007 | https://conductscience.org/library/papers/17630818 | PubMed |
| 15782314 | Cerebral aspergillosis in the critically ill: two cases of successful medical treatment. | Intensive Care Med | 2005 | https://conductscience.org/library/papers/15782314 | PubMed |
| 10074549 | Aspergillus meningitis: diagnosis by non-culture-based microbiological methods and management. | J Clin Microbiol | 1999 | https://conductscience.org/library/papers/10074549 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/8749640
GET https://conductscience.org/api/papers/v1/8749640/authors